What questions are asked in a pharmacovigilance interview?

PV interviews reliably test: AE vs ADR vs SAE definitions, the six seriousness criteria, the ICSR lifecycle (intake to submission), MedDRA hierarchy (SOC to LLT), expedited reporting timelines (7-day and 15-day rules), causality assessment (WHO-UMC scale), aggregate reports (PSUR/PBRER/DSUR), and — at most Pune employers — a live or verbal walkthrough of case processing in Argus or ARISg. HR rounds add shift readiness, since much PV work follows US/EU hours.

What is the 4-minimum-criteria question in PV interviews?

A valid ICSR requires four minimum elements: an identifiable patient, an identifiable reporter, a suspect drug, and an adverse event. This is one of the most frequently asked PV interview questions, and interviewers often follow up with: what do you do if one element is missing? (Answer: the case is invalid for regulatory reporting but you attempt follow-up to complete it — you do not discard it.)

Is there a practical test in pharmacovigilance interviews?

Increasingly yes. Large Pune employers and CROs give candidates a mock adverse event narrative and ask them to identify the four validity elements, assess seriousness and expectedness, propose MedDRA terms, and describe the processing workflow — sometimes verbally, sometimes live in a training instance of Argus. Candidates with hands-on platform training have a decisive advantage in this round.

Pharmacovigilance Interview Questions & Answers (2026) — Freshers to Argus Round

The shape of a PV interview in 2026

Pharmacovigilance hiring at Pune’s pharma companies and CROs — Cipla, Lupin, Glenmark, Sun Pharma on the sponsor side; Syngene, Veeda, IQVIA, ICON on the CRO side — runs a screening call, one or two technical rounds, frequently a case-processing test, and HR. The technical rounds recycle the same core questions because the job itself is standardised: regulators define the work, so employers everywhere test the same knowledge.

That makes PV the most preparable interview in clinical research. Here are the 20 questions that decide most fresher offers.

The definitional core (asked in every single PV interview)

1. Difference between AE, ADR, and SAE. AE: any untoward medical occurrence in a patient administered a product — causality not required. ADR: a response where causality is at least a reasonable possibility. SAE: any AE meeting a seriousness criterion. The trap: interviewers probe whether you know an event can be serious without being severe, and severe without being serious.

2. List the seriousness criteria. Death; life-threatening; hospitalisation or prolongation of existing hospitalisation; persistent or significant disability/incapacity; congenital anomaly/birth defect; other medically important event. Six, in any order, without hesitation — this is a pass/fail question.

3. What are the four minimum criteria for a valid case? Identifiable patient, identifiable reporter, suspect drug, adverse event. Follow-up they love: what if one is missing? The case is invalid for reporting, but you pursue follow-up to complete it — never discard.

4. What is expectedness, and against what is it assessed? An event is unexpected if its nature, severity, or frequency isn’t consistent with the Reference Safety Information — the IB for investigational products, the label (SmPC/PI) for marketed ones. Knowing which document is the RSI in each context is the differentiator.

5. Explain causality assessment. Name the WHO-UMC scale (certain, probable, possible, unlikely, unclassified, unassessable) and the factors: temporal relationship, dechallenge/rechallenge, alternative explanations, known drug profile. Mention that sponsor and investigator assessments can differ and both are recorded.

Process and timelines

6. Walk me through the ICSR lifecycle. Intake → triage (validity + seriousness) → data entry → MedDRA coding → narrative writing → medical review → submission → follow-up. Being able to say what happens at each step is what “hands-on training” means to an interviewer.

7. What are the expedited reporting timelines? Fatal/life-threatening unexpected ICSRs from trials: 7 calendar days (with 8-day follow-up completion); other serious unexpected: 15 days. Post-marketing serious: 15 days. India-specific: SAE reporting to the licensing authority within 24 hours of the sponsor’s knowledge in trials — quoting the NDCT Rules 2019 here is a strong signal.

8. What is E2B? The ICH electronic transmission standard for ICSRs — currently E2B(R3), XML-based, used for submissions to EudraVigilance, FAERS, and VigiFlow. You won’t be asked to write one; you’ll be asked whether you know submissions are electronic and standardised.

9. PSUR vs PBRER vs DSUR — what’s the difference? DSUR: annual safety report for products in development. PSUR/PBRER: periodic reports for marketed products — PBRER is the ICH E2C(R2) evolution emphasising benefit-risk evaluation, not just safety listing. One sentence each is enough; confusing DSUR with PSUR is a common fresher error.

10. What is signal detection? The process of identifying new or changed risk patterns from cumulative data — mention disproportionality analysis (PRR, ROR) and that signals trigger evaluation, not automatic label changes. This flags you as promotable even though freshers don’t do signal work on day one.

MedDRA and coding

11. Explain the MedDRA hierarchy. SOC → HLGT → HLT → PT → LLT, coded at LLT, reported at PT. Give an example: LLT “heart attack” → PT “Myocardial infarction” → SOC “Cardiac disorders.”

12. What is WHO-DD? The drug dictionary used to code suspect and concomitant medications. Knowing MedDRA codes events and WHO-DD codes drugs is exactly the kind of precision this field screens for.

13. Current MedDRA version? It updates twice yearly (March and September). Interviewers care less about the number than whether you know versioning exists and cases get re-coded across migrations.

The platform round

14. Which safety databases have you worked on? The honest fresher answer names training exposure specifically: “hands-on case processing in Argus and ARISg on training instances — intake through submission-ready.” If your course was theory-only, this question is where the interview quietly ends; platform time is what employers are paying the fresher premium for. (It’s why our pharmacovigilance course is built around Argus/ARISg lab work.)

15. Walk me through entering a case in Argus. Book-in (duplicate check first), case data entry across tabs (patient, products, events), MedDRA coding, seriousness/expectedness/causality assessment, narrative generation, quality review, routing through workflow states to submission. Naming the duplicate check as step one reliably impresses.

16. The live test. Many Pune employers hand you a mock narrative — a spontaneous report of, say, a patient hospitalised with rash after starting an antibiotic — and ask you to: validate (four criteria), assess seriousness (hospitalisation → serious), propose the PT, flag expectedness against the label, and outline processing steps and timeline. Practise this end-to-end at least five times before interview day; it’s the round that converts training into offers.

Regulatory context

17. What is PvPI? The Pharmacovigilance Programme of India, coordinated by IPC Ghaziabad, feeding VigiBase via ADR monitoring centres. Sponsor-side interviews add: what’s the marketing authorisation holder’s obligation in India (PSUR submission per CDSCO schedule, local case reporting).

18. What is a PSMF? The Pharmacovigilance System Master File — the living description of a company’s entire PV system. Fresher-level knowledge: it exists, the QPPV owns it, inspectors ask for it first.

HR round specifics for PV

19. Shift readiness. Much Indian PV work follows US/EU business hours; night and rotational shifts are common at CRO delivery centres. Decide your honest answer beforehand — reneging after offer is the fastest way to burn a Pune-sized market.

20. Salary expectations. 2026 fresher reality: ₹3.6–4.5 LPA for PV associates in Pune, senior associates ₹5.5–8.0 by year 3–4 — check your city and level on the salary calculator and quote a grounded range.

One-week prep checklist

Drill questions 1–5 until instant — they are pass/fail
Rehearse the ICSR lifecycle and the Argus walkthrough aloud
Process five mock cases end-to-end, timed
Memorise: 24-hour India SAE rule, 7/15-day expedited rules, twice-yearly MedDRA versioning
Set your salary range from the PV salary report

Pharmacovigilance Interview Questions & Answers (2026): Screening to the Argus Round